Medelis is a specialty oncology CRO focused on preclinical and phase 1 through phase 3 oncology trials in North America and E ... urope. Founded in 2003, Medelis provides sponsors with oncology expertise from drug development thought-leadership to a highly skilled clinical operations team, handling complex oncology trials in all indications, including cutting-edge immunotherapy treatments. read more